Trilogy Writing and Consulting Logo

Glossary Terms

Integrated Summary of Safety

A document, unique to regulatory New Drug Application (NDA) submission for the United States, which evaluates the overall summaries and statistical analyses of the combined safety data from the various clinical studies conducted during drug testing. It is submitted to the Food and Drug Administration (FDA) in section 5.3.5.3 of the CTD.

Use our tool to look up the definition of terms in our glossary.